Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Augmentation for SSRI-Resistant Civilian PTSD
NCT00215241Phase 3Completed
- Sponsor
- Duke University
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone in post-traumatic stress disorder (PTSD), sponsored by Duke University. Started Apr 2004; status: completed.
02
Drugs
risperidone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00215241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215241.